SI1827386T1 - Oralni sestavki za absorpcijo fosforjevih spojin - Google Patents
Oralni sestavki za absorpcijo fosforjevih spojinInfo
- Publication number
- SI1827386T1 SI1827386T1 SI200531182T SI200531182T SI1827386T1 SI 1827386 T1 SI1827386 T1 SI 1827386T1 SI 200531182 T SI200531182 T SI 200531182T SI 200531182 T SI200531182 T SI 200531182T SI 1827386 T1 SI1827386 T1 SI 1827386T1
- Authority
- SI
- Slovenia
- Prior art keywords
- phosphorus compounds
- absorption
- oral compositions
- present
- hyperphosphatemia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000015A ITME20040015A1 (it) | 2004-12-07 | 2004-12-07 | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
EP05810997A EP1827386B1 (en) | 2004-12-07 | 2005-11-29 | Oral compositions for absorption of phosphorus compounds |
PCT/EP2005/056289 WO2006061336A2 (en) | 2004-12-07 | 2005-11-29 | Oral compositions for absorption of phosphorus compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1827386T1 true SI1827386T1 (sl) | 2011-01-31 |
Family
ID=36035790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200531182T SI1827386T1 (sl) | 2004-12-07 | 2005-11-29 | Oralni sestavki za absorpcijo fosforjevih spojin |
Country Status (21)
Country | Link |
---|---|
US (4) | US7815898B2 (sl) |
EP (1) | EP1827386B1 (sl) |
JP (1) | JP5049135B2 (sl) |
KR (1) | KR101283820B1 (sl) |
CN (1) | CN101068535A (sl) |
AT (1) | ATE481091T1 (sl) |
BR (1) | BRPI0518517A2 (sl) |
CA (1) | CA2587924C (sl) |
CY (1) | CY1110985T1 (sl) |
DE (1) | DE602005023648D1 (sl) |
DK (1) | DK1827386T3 (sl) |
ES (1) | ES2352957T3 (sl) |
HR (1) | HRP20100653T1 (sl) |
IT (1) | ITME20040015A1 (sl) |
MX (1) | MX2007006704A (sl) |
PL (1) | PL1827386T3 (sl) |
PT (1) | PT1827386E (sl) |
RS (1) | RS51507B (sl) |
RU (1) | RU2392926C2 (sl) |
SI (1) | SI1827386T1 (sl) |
WO (1) | WO2006061336A2 (sl) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
JP2009507019A (ja) | 2005-09-02 | 2009-02-19 | ジェンザイム・コーポレーション | リン酸塩を除去する方法およびそれに使用される重合体 |
ITRM20060204A1 (it) * | 2006-04-10 | 2007-10-11 | Vincenzo Savica | Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche |
JP2009542653A (ja) * | 2006-07-05 | 2009-12-03 | ジェンザイム コーポレーション | リン酸塩過剰血症のための鉄(ii)含有治療剤 |
US7943597B2 (en) * | 2008-04-08 | 2011-05-17 | Cypress Pharmaceutical, Inc. | Phosphate-binding chitosan and uses thereof |
WO2009126145A1 (en) * | 2008-04-08 | 2009-10-15 | Cypress Pharmaceutical, Inc. | Phosphate-binding chitosan and uses thereof |
US8877907B2 (en) | 2010-06-07 | 2014-11-04 | The Johns Hopkins University | Molecularly imprinted polymers |
US9314523B2 (en) | 2010-09-21 | 2016-04-19 | Elwha Llc | Ingestible salt grabber |
EP2441436A1 (de) * | 2010-10-13 | 2012-04-18 | Fresenius Medical Care Deutschland GmbH | Phosphatbinderformulierung zur einfachen Einnahme |
WO2012098562A2 (en) | 2011-01-19 | 2012-07-26 | Panacea Biotec Limited | Liquid oral compositions of lanthanum salts |
WO2012143008A1 (en) | 2011-04-20 | 2012-10-26 | Gumlink A/S | Reduction of the level of free phosphorus compounds in the digestive juice |
WO2012143011A1 (en) | 2011-04-20 | 2012-10-26 | Gumlink A/S | Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice |
BR112013031539A2 (pt) * | 2011-06-08 | 2019-07-30 | Kai Pharmaceuticals Inc | agentes terapêuticos para regular fósforo sérico |
EP3653061A1 (en) * | 2012-09-04 | 2020-05-20 | The Board of Regents of the University of Texas System | Citrate-rich calcium-magnesium supplement and uses thereof |
WO2014166545A1 (en) | 2013-04-12 | 2014-10-16 | Cm&D Pharma Ltd | Compositions comprising a mixture of elastomers and chitosan and use thereof for treating disorders of phosphorous mineral metabolism |
WO2014197725A1 (en) | 2013-06-05 | 2014-12-11 | Tricida, Inc. | Proton-binding polymers for oral administration |
EP2818176A1 (en) * | 2013-06-27 | 2014-12-31 | Virbac | Composition for the treatment of progressive renal diseases |
CN103536977A (zh) * | 2013-11-04 | 2014-01-29 | 于杰 | 血液灌流器 |
US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
MA41150B1 (fr) | 2014-12-10 | 2020-06-30 | Tricida Inc | Polymères de liaison aux protons pour administration orale |
MA44875A (fr) | 2016-05-06 | 2019-03-13 | Tricida Inc | Compositions pour le traitement de troubles acido-basiques |
US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
AU2018360867A1 (en) | 2017-11-03 | 2020-04-30 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
CN111727037A (zh) * | 2017-11-29 | 2020-09-29 | 世展科技股份有限公司 | 肠溶型医药组合物及其用途 |
US11273123B2 (en) | 2018-07-18 | 2022-03-15 | USpharma Ltd | Chewable pharmaceutical dosage forms |
CN109528764B (zh) * | 2018-09-30 | 2021-04-06 | 北京市中关村医院 | 一种凝胶基层状无机物磷结合剂及其制备方法和用途 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3818807A (en) * | 1972-12-06 | 1974-06-25 | Eng Concrete Placer Inc | Slurry pump piston seal |
US4181718A (en) * | 1975-12-29 | 1980-01-01 | Mason Norbert S | Polyanion-stabilized aluminum hydrogels |
US4163777A (en) * | 1977-04-29 | 1979-08-07 | Lewis/Howe Company | Controlled antacid delivery form and method of treatment therewith |
US4163177A (en) * | 1977-10-17 | 1979-07-31 | Ward Derrick A | Oscillation generator providing oscillations of varying amplitude |
US4160820A (en) * | 1977-11-28 | 1979-07-10 | General Mills, Inc. | Plaque inhibiting composition and method |
US4386106A (en) * | 1981-12-01 | 1983-05-31 | Borden, Inc. | Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition |
US4515769A (en) * | 1981-12-01 | 1985-05-07 | Borden, Inc. | Encapsulated flavorant material, method for its preparation, and food and other compositions incorporating same |
US4512968A (en) * | 1982-11-30 | 1985-04-23 | Lion Corporation | Oral compositions |
DE3686275T2 (de) * | 1985-01-11 | 1993-03-18 | Teijin Ltd | Praeparate mit verzoegerter freisetzung. |
JPS61161216A (ja) * | 1985-01-11 | 1986-07-21 | Teijin Ltd | キトサン類を用いた徐放性医薬品組成物 |
JPS62132830A (ja) * | 1985-12-05 | 1987-06-16 | Teijin Ltd | 徐放性医薬品組成物 |
JPS63310833A (ja) * | 1987-06-10 | 1988-12-19 | Nippon Medical Supply Corp | リン吸着カプセル |
DE3936319C3 (de) * | 1989-11-01 | 1997-05-07 | Bartz Volker | Phosphatbinder zur oralen Verabreichung |
US5030459A (en) * | 1989-11-07 | 1991-07-09 | Warner-Lambert Company | High impact mint flavor for high base chewing gum |
JP2884124B2 (ja) * | 1992-01-31 | 1999-04-19 | 鈴与株式会社 | リン吸着剤 |
US5496545A (en) * | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
DE69705877T2 (de) * | 1996-03-05 | 2002-06-06 | Mitsubishi Chem Corp | Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie |
IE980990A1 (en) * | 1998-11-27 | 2000-05-31 | Fuisz Internat Ltd | Composition and Method for Medicated Chewing Gum Delivery System |
DE19917705C1 (de) * | 1999-04-20 | 2000-12-28 | Vitasyn Gmbh | Mittel zur Therapie von Hyperphosphatämie |
US6645535B2 (en) * | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
FI121528B (fi) * | 2000-10-30 | 2010-12-31 | Biohit Oyj | Farmaseuttinen koostumus syöpään sairastumisen riskin vähentämiseen paikallisesti sitomalla asetaldehydi syljessä, mahalaukussa tai paksusuolessa |
US20030072841A1 (en) * | 2001-03-19 | 2003-04-17 | The Procter & Gamble Campany | Polybutene containing chewing gum and confection |
ITMI20012320A1 (it) * | 2001-11-06 | 2003-05-06 | Perfetti Van Melle Spa | Composizioni orali solide anti-tartaro e anti-placca batterica, utilicome coadiuvanti nell'igiene odonto-stomatologica |
AU2002364491A1 (en) * | 2002-01-03 | 2003-07-30 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Edible compositions capable of removing oral biofilm |
US7244455B2 (en) * | 2002-01-16 | 2007-07-17 | Warner-Lambert Company | Center-filled chewing gum containing a deliverable form of calcium |
SE0302947D0 (sv) * | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
DK1660104T3 (da) * | 2003-08-26 | 2010-06-21 | Shire Holdings Ag | Farmaceutisk formulering indeholdende lanthanforbindelser |
US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
US8323683B2 (en) * | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
US20070207206A1 (en) * | 2006-03-02 | 2007-09-06 | Rice Bronwyn C | Chewable pain formula |
-
2004
- 2004-12-07 IT IT000015A patent/ITME20040015A1/it unknown
-
2005
- 2005-11-29 ES ES05810997T patent/ES2352957T3/es active Active
- 2005-11-29 DE DE602005023648T patent/DE602005023648D1/de active Active
- 2005-11-29 SI SI200531182T patent/SI1827386T1/sl unknown
- 2005-11-29 BR BRPI0518517-3A patent/BRPI0518517A2/pt not_active IP Right Cessation
- 2005-11-29 PL PL05810997T patent/PL1827386T3/pl unknown
- 2005-11-29 KR KR1020077012746A patent/KR101283820B1/ko not_active IP Right Cessation
- 2005-11-29 EP EP05810997A patent/EP1827386B1/en active Active
- 2005-11-29 PT PT05810997T patent/PT1827386E/pt unknown
- 2005-11-29 RU RU2007125702/15A patent/RU2392926C2/ru not_active IP Right Cessation
- 2005-11-29 WO PCT/EP2005/056289 patent/WO2006061336A2/en active Application Filing
- 2005-11-29 CA CA2587924A patent/CA2587924C/en not_active Expired - Fee Related
- 2005-11-29 US US11/792,047 patent/US7815898B2/en not_active Expired - Fee Related
- 2005-11-29 JP JP2007544881A patent/JP5049135B2/ja not_active Expired - Fee Related
- 2005-11-29 MX MX2007006704A patent/MX2007006704A/es active IP Right Grant
- 2005-11-29 DK DK05810997.6T patent/DK1827386T3/da active
- 2005-11-29 CN CNA2005800414580A patent/CN101068535A/zh active Pending
- 2005-11-29 RS RSP-2010/0513A patent/RS51507B/en unknown
- 2005-11-29 AT AT05810997T patent/ATE481091T1/de active
-
2010
- 2010-08-23 US US12/861,539 patent/US20100316578A1/en not_active Abandoned
- 2010-09-16 US US12/883,498 patent/US8518379B2/en not_active Expired - Fee Related
- 2010-11-29 HR HR20100653T patent/HRP20100653T1/hr unknown
- 2010-12-10 CY CY20101101144T patent/CY1110985T1/el unknown
-
2014
- 2014-08-18 US US14/462,038 patent/US20140356297A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2007125702A (ru) | 2009-01-20 |
CA2587924C (en) | 2013-08-20 |
ITME20040015A1 (it) | 2005-03-07 |
WO2006061336A2 (en) | 2006-06-15 |
US20080125394A1 (en) | 2008-05-29 |
KR101283820B1 (ko) | 2013-07-15 |
US20110002858A1 (en) | 2011-01-06 |
US8518379B2 (en) | 2013-08-27 |
JP5049135B2 (ja) | 2012-10-17 |
EP1827386A2 (en) | 2007-09-05 |
JP2008523022A (ja) | 2008-07-03 |
BRPI0518517A2 (pt) | 2008-11-25 |
DK1827386T3 (da) | 2011-07-11 |
RU2392926C2 (ru) | 2010-06-27 |
ES2352957T3 (es) | 2011-02-24 |
US20100316578A1 (en) | 2010-12-16 |
US20140356297A1 (en) | 2014-12-04 |
KR20070090904A (ko) | 2007-09-06 |
MX2007006704A (es) | 2008-01-16 |
RS51507B (en) | 2011-06-30 |
CN101068535A (zh) | 2007-11-07 |
PT1827386E (pt) | 2010-12-03 |
PL1827386T3 (pl) | 2011-05-31 |
ATE481091T1 (de) | 2010-10-15 |
DE602005023648D1 (de) | 2010-10-28 |
HRP20100653T1 (hr) | 2011-01-31 |
CA2587924A1 (en) | 2006-06-15 |
EP1827386B1 (en) | 2010-09-15 |
CY1110985T1 (el) | 2015-06-11 |
US7815898B2 (en) | 2010-10-19 |
WO2006061336A3 (en) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1827386T1 (sl) | Oralni sestavki za absorpcijo fosforjevih spojin | |
IL228952B (en) | Use of preparations containing iron citrate to prepare drugs to reduce serum phosphate levels | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20075111L (no) | Farmasoytisk sammensetning | |
EP2545939A3 (en) | Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
HK1076605A1 (en) | Formulations | |
NO20071901L (no) | Substituerte bisykliske imidazo-3-ylamin sammensetninger | |
ZA200606804B (en) | Pharmaceutical composition for treatment of immunological disorders | |
IL210756A0 (en) | Carbostyril compound, process for their preparation and pharmaceutical compositions containing them | |
DK2254549T4 (da) | Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser | |
TW200745122A (en) | New compounds I | |
IL188980A0 (en) | Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily | |
EP1846000A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH BISPHOSPHONATE TO IMPROVE ORAL ABSORPTION | |
IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
EA201300539A1 (ru) | Твердая композиция для приема внутрь (варианты), способ терапевтической или нетерапевтической профилактики желудочно-кишечных расстройств или поддержания здорового состояния желудочно-кишечного тракта с ее помощью (варианты) и упаковка, ее содержащая | |
EP1941896A4 (en) | COMPOSITION CONTAINING A DIPEPTIDE FOR ORAL ADMINISTRATION | |
IL179530A0 (en) | Novel compounds, pharmaceutical compositions containing same and methods of use for same | |
TW200745133A (en) | New compounds II | |
GB0620619D0 (en) | Novel compounds | |
TNSN08242A1 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
ATE355830T1 (de) | Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure | |
ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. | |
EA200970097A1 (ru) | Фармацевтическая композиция, содержащая бикалутамид, и способ её применения |